healthy volunteer
Conditions
Interventions
Intake of nanoparticle curcumin
Sponsors
Kyoto University Hospital, Outpatient Oncology Unit
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy volunteeer who provided written informed consent
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the pharmacokinetic variables including Cmax, T1/2 and AUC after nanoparticle curcumin intake | — |
Countries
Japan
Outcome results
None listed